Ameritas Investment Partners Inc. boosted its holdings in shares of RxSight by 39.2% during the 1st quarter.

Source: https://www.americanbankingnews.com/2023/09/12/bridger-management-llc-invests-1-65-million-in-rxsight-inc-nasdaqrxst.html

Needham & Company LLC decreased their price target on RxSight from $36.00 to $30.00 and set a “buy” rating on the stock in a research report on Friday, November 10th.

Source: https://www.etfdailynews.com/2023/12/15/insider-selling-rxsight-inc-nasdaqrxst-director-sells-507715-02-in-stock/

Wells Fargo & Company upped their price target on shares of RxSight from $17.00 to $27.00 in a report on Monday, June 5th.

Source: https://www.etfdailynews.com/2023/09/11/rxsight-inc-nasdaqrxst-director-bakker-juliet-tammenoms-sells-19967-shares/